Better Dividend: Abbott Laboratories (ABT) vs. AbbVie Inc (ABBV)
High yields aren't everything when you're searching for the perfect dividend stock.
Posts Tagged ‘Pfizer Inc (PFE)’
Three Things You Need to Know From Merck & Co., Inc. (MRK)’s Q2 Earnings
The good news was that the big pharmaceutical company beat earnings estimates. Merck & Co., Inc.
Three Potential Solutions for Pfizer Inc. (PFE)’s Generic Drug Business
The company broke open a bombshell on Monday when it announced that it would break its business into three new divisions -- two focused around drugs, vaccines, and consumer products...
Oracle Corporation (ORCL), Pfizer Inc. (PFE): Here’s What This Huge 737% Gainer Has Been Buying and Selling
Today, let's look at investing giant Donald Yacktman, who founded Yacktman Asset Management in 1992.
Pfizer Inc. (PFE)’s Healthy Quarter Can’t Stop the Dow Jones Industrial Average (.DJI)’s Slide
So much for the stock market gains that dominated most of today's trading.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): It’s All About Drugs Today
This morning the Dow Jones Industrial Average (INDEXDJX:.DJI)'s two big drug companies and a number of smaller drug-related companies announced earnings.
AstraZeneca plc (ADR) (AZN) and Bristol Myers Squibb Co. (BMY): 2 Keys to Success for This Diabetes Drug’s Second Chance
AstraZeneca plc (ADR) (NYSE:AZN) and Bristol Myers Squibb Co. (NYSE:BMY) announced last week that they are making another attempt at U.S.
Pfizer Inc. (PFE)’s Generic Split Buffers the Dow’s Falling Financials
The Dow Jones Industrial Average is kicking off the new week in the red as a disappointment from the flourishing housing sector pressures the markets.
Three Things You Need to Know From AbbVie Inc (ABBV)’s Q2 Earnings
It's easy to forget that AbbVie Inc (NYSE:ABBV) is technically only seven-months old.
Pfizer Inc. (PFE): As Healthcare Demand Rises, So Will This Company’s Profits
The aging population as well as the higher number of people who will receive benefits under new healthcare laws should combine to produce rising profits for a variety of companies...
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Dow Components to Watch This Coming Week
After last week, when eight of the Dow Jones Industrial Average's 30 components reported earnings, this week may seem slow, with only four companies releasing their second-quarter...
The Procter & Gamble Company (PG), Merck & Co., Inc. (MRK): The Six Biggest Risk Factors for Insomnia
We often take sleep, the number of hours we get to sleep, or the quality of sleep we get, for granted.
Questcor Pharmaceuticals Inc (QCOR), Biogen Idec Inc (BIIB): A Biotech Betting Everything on a Single Drug
Despite some negative news, mainly related to reimbursement issues and excess stock booking, Questcor Pharmaceuticals Inc (NASDAQ:QCOR) recently gained solid momentum due to a...
Are Eli Lilly & Co. (LLY) Earnings Headed Down?
Eli Lilly & Co. (NYSE:LLY) will release its quarterly report tomorrow, and recent share-price declines show that investors are somewhat nervous about the company's prospects.
Eli Lilly & Co. (LLY): What Does the Patent Cliff Mean for This Drugmaker?
For Eli Lilly & Co. (NYSE:LLY), history is repeating itself once again.
Onyx Pharmaceuticals, Inc. (ONXX), Amgen, Inc. (AMGN): Will This Biotech Bidding War Lead You to Larger Gains?
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) added 3% to its one-month 60% gains on Monday because of continued speculation of a buyout.
Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK): Three Healthcare Stocks for Growth and Dividends
The healthcare sector has been one of the best sectors for dividend hunters -- most of the companies operating in the sector generate massive cash flow and payout a large chunk...
Johnson & Johnson (JNJ), Pfizer Inc. (PFE): Large Cap Stocks Are Cheaper Than They Appear
Uncertainty creates opportunity for long-term investors, and there is a lot of uncertainty in the healthcare sector right now.
Medivation Inc (MDVN), Questcor Pharmaceuticals Inc (QCOR): The Best Performing Biotech Stocks of the Last Decade
Biotech is booming these days. But that's not a new story by any means. Biotech stocks as a group have done very well over the past several years.
Onyx Pharmaceuticals, Inc. (ONXX), Amgen, Inc. (AMGN): Why Getting Rich Quick Doesn’t (Always) Pay
We have a bona fide biotech soap opera going on these days. Spurned love. Possible romance. Disgruntled suitor. And, of course, the unknown villain.
Billionaire Stanley Druckenmiller’s Cheap Stock Picks Include D.R. Horton, Inc. (DHI)
In May, billionaire Stanley Druckenmiller- the former head of Duquesne Capital and portfolio manager for George Soros- filed his 13F with the SEC, disclosing many of his long ...
Is Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Making a Comeback?
The recent rally in shares of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) may suggest investors are regaining some confidence in this pharmaceutical manufacturer.
Anatomy of an Earnings Jump: Cubist Pharmaceuticals Inc (CBST)
Shares of Cubist Pharmaceuticals Inc (NASDAQ:CBST) exploded upward on Friday, finishing up over 9%.
Amgen, Inc. (AMGN)’s Acquisition Ambition Leads Biotechs’ Rise
Biotech's the biggest boom-or-bust business on the market, with regulatory approvals and clinical trial results routinely sending stocks hurtling up or down by significant amounts...
Bristol Myers Squibb Co. (BMY), Gilead Sciences, Inc. (GILD): Did Someone Just Cure AIDS for $200,000?
According to multiple reports , Harvard researchers Timothy Henrich and Daniel Kuritzkes have recently noted a surprising side-effect to cancer treatments performed on two separate...
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): The Five Most Misdiagnosed Diseases
There's little denying that the technological, research, and medicinal aspects of patient care are improving at breakneck speed.
Celgene Corporation (CELG): Expanding Labels to Expand Margins
In an industry where buyouts are commonplace and small-cap biotechs burn through cash rapidly, optimizing operating cash flow can be essential to a company's financial health.
Four Potential Suitors for Onyx Pharmaceuticals, Inc. (ONXX)
The "people familiar with the matter" are out in full force spouting off about who's bidding for Onyx Pharmaceuticals, Inc.
Abbott Laboratories (ABT), Pfizer Inc. (PFE): How Will the Patent Cliff Affect These Pharmaceuticals?
The pharmaceutical sector is mainly about the pipeline of new products and patents.
GlaxoSmithKline plc (ADR) (GSK), Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): These Biotech Companies Are Facing Setbacks, but Investors Shouldn’t Worry
Most recently, executives working for the U.K.-based GlaxoSmithKline plc (ADR) (NYSE:GSK) in China have been accused of, and confessed to, serious corruption and tax-related ...
A Look at Novartis AG (ADR) (NVS)’ Second Quarter
The story of the second quarter for Novartis AG (ADR) (NYSE:NVS) offered mixed results for investors. The company's net sales were up 1%, and EPS was down 6% year over year.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Which Pharmaceutical Giant Is the Best Investment?
Amid sluggish sales growth, the Pharmaceutical Industry giants are struggling with declining revenues and profits.
Is Pfizer Inc. (PFE) Destined for Greatness?
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown.
Merck & Co., Inc. (MRK): This Pharmaceutical Company Is Poised for Wellness
Sustainability and a strong pipeline are the two tests that best evaluate a pharmaceutical company. Merck & Co., Inc. (NYSE:MRK) scores high on both counts.
Pfizer Inc. (PFE): Pharma Stock Could Make Traders 122% on a Catch-up Rally
One of the strongest market sectors so far in 2013 has been pharmaceuticals.
Pfizer Inc. (PFE): Book A 120% Gain With This Pharma Stock’s Rebound
One of the strongest market sectors this year has been pharmaceuticals.
Onyx Pharmaceuticals, Inc. (ONXX), Alexion Pharmaceuticals, Inc. (ALXN): 3 Biotechs That Could Be Bought Out This Year
Chances are that a few biotech companies will be scooped up by larger players over the coming months.
GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX), Pfizer Inc. (PFE): 3 Potential Game Changers for COPD
Over 13 million Americans have it. More than 120,000 of them die every year.
Pfizer Inc. (PFE), Cliffs Natural Resources Inc (CLF), Intel Corporation (INTC): Short Sellers Have These Seven Well-Known Stocks In Their Sights
Indeed, many hedge fund managers that tend to make a living from short selling have moved to the sidelines, waiting for the market to switch direction before loading up on shorts...
Exxon Mobil Corporation (XOM), AT&T Inc. (T), Apple Inc. (AAPL): These 15 Stocks Are the Most Generous Dividend-Payers in the Market
Dividend stocks have gotten incredibly popular among investors as the search for income has led many to take on more risk in their portfolios in order to generate the cash flow...
Amgen, Inc. (AMGN), DaVita HealthCare Partners Inc (DVA): Four Robust Investments in Dialysis and Diabetes
Shares of the two largest kidney care companies in the United States, DaVita HealthCare Partners Inc (NYSE:DVA) and Fresenius Medical Care AG & Co.
Pharmacyclics, Inc. (PCYC): Will This Be the Breakthrough of All Breakthrough Therapy Drugs?
In July 2012, the Food and Drug Administration Safety and Innovation Act was signed into law; and little did we know at the time, but the drug development process was about to...
Exploding Pipeline Makes BioMarin Pharmaceutical Inc. (BMRN) Attractive Takeover Target
The Orphan Drug pipeline of BioMarin Pharmaceutical Inc.
Microsoft Corporation (MSFT), Pfizer Inc. (PFE), and Northrop Grumman Corporation (NOC): Three Good Companies With Unloved Stocks
The co-managers of Guinness Atkinson Inflation Managed Dividend Fund (GAINX) describe Microsoft Corporation (NASDAQ:MSFT), Pfizer Inc. (NYSE:PFE), and Northrop Grumman Corporation...
Drug Deal Can Only Help VIVUS, Inc. (VVUS) So Much
VIVUS, Inc. (NASDAQ:VVUS) has found an Italian to help it out.
Who Could Buy Onyx Pharmaceuticals, Inc. (ONXX) and at What Price?
Recently Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) rejected a $10 billion takeover offer from Amgen, Inc. (NASDAQ:AMGN).
Alcoa Inc (AA), Intel Corporation (INTC): The Dow Jones Industrial Average (.DJI)’s 5 Most Hated Stocks
What happens when the unstoppable force known as the Dow Jones Industrial Average (Dow Jones Indices:.DJI) meets the immovable object known as short-sellers? Thus far, the answer...
Is Merck & Co., Inc. (MRK) Destined for Greatness?
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown.
Gilead Sciences, Inc. (GILD), Johnson & Johnson (JNJ): Is a Breakthrough Treatment on the Way for People With HIV?
We as a country have a come a long way over the past two decades with regard to treating HIV and reducing the number of AIDS diagnoses.
